Log in

China Pharma Stock Forecast, Price & News

+0.03 (+6.43 %)
(As of 10/21/2020 12:00 AM ET)
Today's Range
Now: $0.50
50-Day Range N/A
52-Week Range
Now: $0.50
Volume3.72 million shs
Average Volume2.14 million shs
Market Capitalization$21.64 million
P/E RatioN/A
Dividend YieldN/A
China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products primarily to hospitals and private retailers in the People's Republic of China. The company offers products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. Its products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain; Propylgallate and Ozagrel Sodium to treat cerebral thrombosis, coronary heart disease, and after surgery complications; Alginic Sodium Diester injection for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Bumetanide to treat edema diseases; and Candesartan for hypertension. It also provides Roxithromycin dispersible tablets for pharyngitis and tonsillitis; Cefaclor dispersible tablets for tympanitis, lower respiratory tract infection, urinary tract infections, and skin/skin tissue infection; Cefalexin capsules for acute tonsillitis; Anhydroandrographolide for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Clarithromycin granules and capsules; and Naproxen Sodium and PseudophedrineHydrochlorida sustained release tablets. In addition, the company offers Hepatocyte growth-promoting factor, Tiopronin, Compound Ammonium Glycyrrhetate S, and Omeparzole for the treatment of digestive diseases. Further, it provides Vitamin B6 injection; and Granisetron Hydrochloride injection to treat nausea and vomiting caused by radiotherapy and chemotherapy during the treatment of malignant tumors. The company offers its products through distributors, as well as through its network of 16 sales offices and approximately 1,000 sales representatives. China Pharma Holdings, Inc. is headquartered in Haikou, the People's Republic of China.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.20 out of 5 stars

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Phone86 898 6681 1730



Sales & Book Value

Annual Sales$10.92 million
Book Value$0.21 per share


Net Income$-20,700,000.00
Net Margins-183.34%


Market Cap$21.64 million
Next Earnings DateN/A
OptionableNot Optionable
+0.03 (+6.43 %)
(As of 10/21/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CPHI News and Ratings via Email

Sign-up to receive the latest news and ratings for CPHI and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

China Pharma (NYSE:CPHI) Frequently Asked Questions

Who are some of China Pharma's key competitors?

What other stocks do shareholders of China Pharma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other China Pharma investors own include iShares Silver Trust (SLV), Check-Cap (CHEK), ContraFect (CFRX), Clear Channel Outdoor (CCO), Boxlight (BOXL), BioNano Genomics (BNGO), Athersys (ATHX), Assertio (ASRT), Ampio Pharmaceuticals (AMPE) and AMC Entertainment (AMC).

Who are China Pharma's key executives?

China Pharma's management team includes the following people:
  • Ms. Zhilin Li, Pres, CEO, Chairman & Interim CFO (Age 67, Pay $241.6k)
  • Sam Hsing, Corp. VP
  • Ms. Diana Huang, BOD Sec. & IRO

What is China Pharma's stock symbol?

China Pharma trades on the New York Stock Exchange (NYSE) under the ticker symbol "CPHI."

How do I buy shares of China Pharma?

Shares of CPHI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is China Pharma's stock price today?

One share of CPHI stock can currently be purchased for approximately $0.50.

How big of a company is China Pharma?

China Pharma has a market capitalization of $21.64 million and generates $10.92 million in revenue each year. China Pharma employs 228 workers across the globe.

What is China Pharma's official website?

The official website for China Pharma is www.chinapharmaholdings.com.

How can I contact China Pharma?

China Pharma's mailing address is Second Floor No. 17 Jinpan Road, Haikou F4, 570216. The company can be reached via phone at 86 898 6681 1730 or via email at [email protected]

This page was last updated on 10/22/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.